HK99694A - Method for selective methylation of erythromycin a derivatives - Google Patents

Method for selective methylation of erythromycin a derivatives

Info

Publication number
HK99694A
HK99694A HK99694A HK99694A HK99694A HK 99694 A HK99694 A HK 99694A HK 99694 A HK99694 A HK 99694A HK 99694 A HK99694 A HK 99694A HK 99694 A HK99694 A HK 99694A
Authority
HK
Hong Kong
Prior art keywords
erythromycin
derivatives
selective methylation
methylation
selective
Prior art date
Application number
HK99694A
Other languages
English (en)
Inventor
Yoshiaki Watanabe
Shigeo Morimoto
Masami Goi
Morihiro Mitsukuchi
Takashi Adachi
Jozi Nakagami
Toshifumi Asaka
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13375748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK99694(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of HK99694A publication Critical patent/HK99694A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK99694A 1984-04-06 1994-09-15 Method for selective methylation of erythromycin a derivatives HK99694A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59068509A JPS60214796A (ja) 1984-04-06 1984-04-06 ６−０−メチルエリスロマイシン類の製法

Publications (1)

Publication Number Publication Date
HK99694A true HK99694A (en) 1994-09-23

Family

ID=13375748

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99694A HK99694A (en) 1984-04-06 1994-09-15 Method for selective methylation of erythromycin a derivatives

Country Status (17)

Country Link
US (1) US4672109A (de)
EP (1) EP0158467B1 (de)
JP (1) JPS60214796A (de)
KR (1) KR910007572B1 (de)
AR (1) AR240833A1 (de)
AT (1) ATE44384T1 (de)
AU (1) AU567803B2 (de)
CA (1) CA1225637A (de)
DE (1) DE3571323D1 (de)
DK (1) DK172481B1 (de)
ES (1) ES541898A0 (de)
FI (1) FI77250C (de)
GE (1) GEP19960318B (de)
HK (1) HK99694A (de)
PT (1) PT80237B (de)
SU (1) SU1577700A3 (de)
ZA (1) ZA852349B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
EP0201166B1 (de) 1985-03-12 1990-02-07 Beecham Group Plc Erythromycin-Derivate
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5808017A (en) * 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
DK0915899T3 (da) * 1996-07-29 2004-11-29 Abbott Lab Fremstilling af krystallinsk form II af clarithromycin
US5858986A (en) * 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) * 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5929219A (en) * 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
US5852180A (en) * 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
IL135792A0 (en) * 1997-12-01 2001-05-20 Abbott Lab 6-o-alkyl derivatives of erythronolide b
US5932710A (en) * 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
IL124084A0 (en) * 1998-04-14 1999-04-11 Chemagis Ltd Erythromycin a derivatives and methods for the preparation thereof
IL125372A0 (en) * 1998-07-15 1999-03-12 Chemagis Ltd Erythromycin derivatives and methods for the preparation thereof
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
US6627743B1 (en) 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
WO2001044262A1 (en) * 1999-12-16 2001-06-21 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph iv
CA2397092A1 (en) 2000-01-11 2001-07-19 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2001064224A1 (en) 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
ATE338053T1 (de) * 2000-03-15 2006-09-15 Hanmi Pharm Ind Co Ltd Verfahren zur herstellung von clarythromycin mit nicht pharmazeutischer qualität
DK1283821T3 (da) 2000-05-15 2004-07-12 Ranbaxy Lab Ltd Omkostningseffektiv fremgangsmåde til selektiv methylering af erythromycin A-derivater
DE60114028T2 (de) 2000-08-23 2006-07-13 Wockhardt Ltd. Verfahren zur herstellung von wasserfreiem azithromycin
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
CA2481271A1 (en) * 2002-04-03 2003-10-09 Ranbaxy Laboratories Limited Clarithromycin formulations having improved bioavailability
US6843854B2 (en) 2002-05-31 2005-01-18 Purdue Research Foundation Method and apparatus for separating a component from a mixture
ES2221807B1 (es) * 2003-06-24 2005-12-16 Ercros Industrial, S.A. Un procedimiento para la obtencion de claritromicina.
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1648418A4 (de) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (de) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In Antibiotisches produkt, seine verwendung und formulierung
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8124744B2 (en) 2006-05-01 2012-02-28 Taisho Pharmaceutical Co., Ltd. Macrolide derivatives
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US4166901A (en) * 1978-01-03 1979-09-04 Pfizer Inc. 4"-Deoxy-4"-arylglyoxamido- and aroylthioformamido derivatives of oleandomycin and its esters
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896095A (ja) * 1981-11-30 1983-06-07 Taisho Pharmaceut Co Ltd １１−ｏ−アルキルエリスロマイシンａ誘導体
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
JPS5896098A (ja) * 1981-12-03 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
IL75908A0 (en) * 1984-08-31 1985-12-31 Abbott Lab Macrolide alkylation process

Also Published As

Publication number Publication date
FI77250C (fi) 1989-02-10
KR850007434A (ko) 1985-12-04
DK172481B1 (da) 1998-11-23
FI77250B (fi) 1988-10-31
GEP19960318B (en) 1996-06-24
DE3571323D1 (en) 1989-08-10
AU4037885A (en) 1985-10-10
PT80237B (pt) 1987-06-17
KR910007572B1 (ko) 1991-09-28
SU1577700A3 (ru) 1990-07-07
ES8602839A1 (es) 1985-12-01
JPH053475B2 (de) 1993-01-14
EP0158467A2 (de) 1985-10-16
AR240833A1 (es) 1991-02-28
EP0158467B1 (de) 1989-07-05
DK152385A (da) 1985-10-07
ZA852349B (en) 1985-11-27
DK152385D0 (da) 1985-04-03
EP0158467A3 (en) 1986-03-19
CA1225637A (en) 1987-08-18
FI851376A0 (fi) 1985-04-04
PT80237A (en) 1985-05-01
AU567803B2 (en) 1987-12-03
ES541898A0 (es) 1985-12-01
FI851376L (fi) 1985-10-07
JPS60214796A (ja) 1985-10-28
US4672109A (en) 1987-06-09
ATE44384T1 (de) 1989-07-15

Similar Documents

Publication Publication Date Title
DE3571323D1 (en) Method for selective methylation of erythromycin a derivatives
DE3661420D1 (en) Method for selective methylation of erythromycin a derivatives
DE3575729D1 (en) 6-o-methylerythromycin a derivative
ZA866443B (en) Erythromycin derivatives
EG17459A (en) Method for preparation 9a-aza-9a-homoerythromycin derivatives
ZA841592B (en) Macrolide derivatives
EP0222186A3 (en) Erythromycin a derivatives
DE3474831D1 (en) C-20- and c-23-modified macrolide derivatives
YU45983A (en) Process for obtaining 9-dihydro-11,12-ketal derivatives of erythromycin a and api-erythromycin a
HUT41404A (en) Process for preparing dihydro-pyridine derivatives
GB2190616B (en) Method for making drill rods
HUT42896A (en) Process for producing antibiotic derivatives
DE3263301D1 (en) Erythromycin a derivatives
GB2168353B (en) Process for preparing nucleoside derivatives
EP0196167A3 (en) Method for adjusting a time delay
DE3468883D1 (en) Macrolide derivatives
ZA841277B (en) C-20-and c-23-modified macrolide derivatives
GB2154606B (en) Selective agent for group a streptococci
ZA861646B (en) Method for selective mythylation of erythromycin a derivatives
DE3565268D1 (en) Novel tylosin derivatives
GR862415B (en) Method for preparing chinolin derivatives
PL242694A1 (en) Method of preparation of erythromycin a
IE840462L (en) Macrolide derivatives
IE840490L (en) Macrolide derivatives
PL241664A1 (en) Method of isolation of cyclic 11,12-carbonate of a erythromycin

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20050321